Kyowa Hakko Kirin Co. Ltd. | Mutual Funds
Mutual Funds that own Kyowa Hakko Kirin Co. Ltd.
Nomura Asset NIKKEI 225 Index ETF (1321)
9,444,000
1.64%
128,000
0.32%
07/31/2018
Vanguard Health Care Fund
5,952,900
1.03%
0
0.21%
06/30/2018
Nikko Asset Listed Index 225 ETF (1330)
4,790,000
0.83%
2,000
0.32%
08/20/2018
Daiwa Asset NIKKEI 225 ETF (1320)
4,228,000
0.73%
-16,000
0.32%
07/31/2018
Government Pension Fund - Global (The)
4,100,499
0.71%
230,499
0.01%
12/31/2017
Nomura Asset TOPIX ETF Fund (1306)
3,956,600
0.69%
62,700
0.1%
07/31/2018
Vanguard Total International Stock Index Fund
3,582,512
0.62%
25,600
0.02%
07/31/2018
Mitsubishi UFJ MAXIS Nikkei 225 ETF (1346)
2,294,000
0.4%
46,000
0.32%
07/31/2018
2,042,000
0.35%
-70,000
2.59%
03/23/2017
T Rowe Price Health Sciences Fund
1,992,700
0.35%
1,992,700
0.28%
06/30/2018
| Address |
Otemachi Financial City Grand Cube
Tokyo Tokyo 100
Japan
|
|
Employees
|
- |
| Website |
http://www.kyowa-kirin.co.jp |
| Updated |
07/08/2019 |
| Kyowa Hakko Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. |
